Drug treatments available for the management of substance use disorders (SUD) present
multiple limitations in efficacy, lack of approved treatments or alarming relapse rates. These …

Background Cannabidiol (CBD) is one of the major constituents of Cannabis sativa L. that
lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing …

Introduction Cannabidiol (CBD) is a phytocannabinoid found in the Cannabis plant. CBD
has received significant medical attention in relation to its anticonvulsant, anxiolytic, and …

Opioid addiction is a chronically relapsing disorder that causes critical public health
problems. Currently, there is a lack of effective drug treatment. Herein, one cannabidiol …

Growing evidence indicates that cannabidiol (CBD), a substance present in the Cannabis
sativa plant, has potential therapeutic value to regulate abnormal emotional memories …

Methamphetamine (MET) is one of the most prevalently abused psychostimulants in the
world with drastic repercussions. Several studies emphasized the inhibitory effect of …

Frontotemporal dementia (FTD) and Alzheimer's disease (AD) share the pathological
hallmark of intracellular neurofibrillary tangles, which result from the hyperphosphorylation …

Cocaine dependence is a highly prevalent disease in modern society and lacks an effective
treatment. Cannabidiol (CBD), a major non-psychoactive constituent of Cannabis sativa, has …

Cannabidiol, as component of cannabis, can potentially hinder the rewarding impact of drug
abuse; however, its mechanism is ambiguous. Moreover, the nucleus accumbens (NAc), as …

Cannabidiol (CBD) is one of the major phytocannabinoids present in the cannabis plant,
with no acute psychotropic effects and a favorable safety and abuse liability profile. Animal …